Stay updated on Eteplirsen in DMD Exon 51 Skipping Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen in DMD Exon 51 Skipping Clinical Trial page.

Latest updates to the Eteplirsen in DMD Exon 51 Skipping Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study record is displayed with its design, eligibility criteria, locations, interventions, and outcome measures, along with record dates and study documents.SummaryDifference47%

- Check15 days agoChange DetectedThe site footer revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedThe page now displays an NIH announcement about the terminology transition from “Artificial Intelligence” to “Super Intelligence,” along with the standard ClinicalTrials.gov site shell, rather than a 403 error.SummaryDifference2%

- Check29 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the previously visible study details with a generic error screen and site navigation. This indicates the page is currently inaccessible due to access restrictions rather than a change to the study information.SummaryDifference17%

Stay in the know with updates to Eteplirsen in DMD Exon 51 Skipping Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen in DMD Exon 51 Skipping Clinical Trial page.